A detailed history of Bank Of America Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, Bank Of America Corp holds 183,897 shares of UTHR stock, worth $63.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
183,897
Previous 121,516 51.34%
Holding current value
$63.4 Million
Previous $27.9 Million 109.86%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $14.2 Million - $19.9 Million
62,381 Added 51.34%
183,897 $58.6 Million
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $10.2 Million - $12.1 Million
48,384 Added 66.16%
121,516 $27.9 Million
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $5.53 Million - $6.61 Million
-25,736 Reduced 26.03%
73,132 $16.1 Million
Q2 2023

Aug 14, 2023

SELL
$205.19 - $232.99 $3.87 Million - $4.39 Million
-18,837 Reduced 16.0%
98,868 $21.8 Million
Q1 2023

May 12, 2023

BUY
$212.99 - $276.17 $2.47 Million - $3.2 Million
11,576 Added 10.91%
117,705 $26.4 Million
Q4 2022

Feb 10, 2023

BUY
$205.95 - $280.43 $3.03 Million - $4.13 Million
14,729 Added 16.11%
106,129 $29.5 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $30.4 Million - $36.5 Million
-149,423 Reduced 62.05%
91,400 $19.1 Million
Q2 2022

Aug 12, 2022

SELL
$174.81 - $241.14 $3.33 Million - $4.59 Million
-19,045 Reduced 7.33%
240,823 $56.7 Million
Q1 2022

May 16, 2022

BUY
$166.16 - $213.96 $14.9 Million - $19.2 Million
89,836 Added 52.83%
259,868 $46.6 Million
Q4 2021

Feb 08, 2022

SELL
$184.32 - $216.08 $2.75 Million - $3.22 Million
-14,918 Reduced 8.07%
170,032 $36.7 Million
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $9.14 Million - $10.9 Million
50,841 Added 37.91%
184,950 $34.1 Million
Q2 2021

Sep 13, 2021

BUY
$170.47 - $211.93 $22.9 Million - $28.4 Million
134,109 New
134,109 $24.1 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $15.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.